Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B.R.E.A.T.H.E. Bronchiolitis RCT: Emergency Assisted Therapy with Heliox
2005-003007-36Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of heliox21 in bronchiolitis (2 arms), sponsored by Imperial College London. Primary endpoints: Primary endpoint for Part 1 and Primary endpoint for Part 2. Started Aug 2005; status: completed.
02
Drugs
heliox21
03
Conditions
bronchiolitis
Beyond the preview
Go deeper on 2005-003007-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003007-36.